MCA registered Company Details
InsightsCompaniesSectorsDirectorsInvestorsCompare
RegisterKaro › MCA registered Company Details

Cyamopsisbiotech

U01136HR2012PTC045395ActivePrivateUnlisted
Last updated: 2026-06-09
30
Compliance Health · F
3 / 9 signals passed

Cyamopsisbiotech is a Private Indian company incorporated in 2018 and based in Haryana, India. Cyamopsisbiotech operates in Agriculture (NIC 01136) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.

Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100
Revenue (latest FY)
—
Awaiting extraction
PAT (latest FY)
—
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
—
—
Filings on Record
0
All current
Incorporated
2018
8 years old
State
Haryana
Sector
Agriculture
NIC 01136
Class
Private
Sub-category
—
Authorized Capital
—
Paid-up Capital
—
Members
—
Last AGM
—
Last Balance Sheet
—
Latest Filing
—
Registered Email
—
Registered Office
—
CyamopsisbiotechTRACXN · PUBLIC DATA
Brand Cyamopsisbiotech · Legal entity Cyamopsisbiotech

Cyamopsisbiotech - Manufacturer of guar gum and its derivatives for various industries.

Total Funding
Latest Round
—
Revenue
Valuation
Funding Rounds
—
Employees
11
Stage
Unfunded
HQ
—
Founded
2018
Source: Tracxn (public profile) · joined to MCA on CIN U01136HR2012PTC045395

Quick facts

Identity · Activity · Auditor · Contact
Registered office
—
NIC code
01136
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
Agriculture
ROC
—
Website
https://cyamopsisbiotech.com
Class · sub-category
Private
Incorporation · Last AGM
— · —

Directors

From MGT-7 annual returnLocked
AM
Arun Malhotra
Whole-time Director
7.3y · Chennai · DIN 5513627
KB
Kunal Bhatia
Additional Director
8.8y · Bengaluru · DIN 4200996
Get the full board of directors

Directors, DINs & appointment history for Cyamopsisbiotech.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 2024+20dfiled
MGT-7FY2024-2526 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 20230dfiled
MGT-7FY2023-2427 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 2022+3dfiled
MGT-7FY2022-2325 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Cyamopsisbiotech.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
686244883HDFC Bank Ltd(Bank)₹7.60 Cr27 Jan 2022Satisfied
365826428ICICI Bank Ltd(Bank)₹2.31 Cr04 Jul 2022Satisfied
492210535HDFC Bank Ltd(Bank)₹16.12 Cr27 Jan 2019Open
549733159Kotak Mahindra Bank Ltd(Bank)₹22.74 Cr12 Mar 2022Open
295981399Kotak Mahindra Bank Ltd(Bank)₹17.29 Cr27 Jan 2020Open
758678957HDFC Bank Ltd(Bank)₹15.47 Cr19 Sep 2023Open
See registered charges & lenders

Charge IDs, lenders & amounts for Cyamopsisbiotech.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

Revenue · PAT · Net worth by FYLocked
FYRevenuePATNet WorthTotal AssetsEmployees
FY2024-25₹12.64 Cr₹68.69 L₹9.39 Cr₹17.20 Cr334
FY2023-24₹11.80 Cr₹68.03 L₹11.05 Cr₹15.94 Cr332
FY2022-23₹10.23 Cr₹59.34 L₹3.67 Cr₹10.53 Cr313
FY2021-22₹9.45 Cr₹70.19 L₹3.44 Cr₹9.57 Cr109
Gain deeper financial insights of this entity

Audited financials & ratios for Cyamopsisbiotech.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Detailed Financials

Income statement + balance sheetLocked
Line itemFY2024-25FY2023-24FY2022-23FY2021-22
Income statement
Revenue from operations₹12.64 Cr₹11.80 Cr₹10.23 Cr₹9.45 Cr
Other income₹38.46 L₹18.63 L₹27.11 L₹17.40 L
Total income₹13.02 Cr₹11.98 Cr₹10.50 Cr₹9.63 Cr
Total expenses₹12.15 Cr₹11.11 Cr₹9.74 Cr₹8.73 Cr
Profit before tax₹89.30 L₹88.44 L₹77.14 L₹91.24 L
Profit / (Loss) after tax₹68.69 L₹68.03 L₹59.34 L₹70.19 L
Balance sheet
Equity / Net worth₹9.39 Cr₹11.05 Cr₹3.67 Cr₹3.44 Cr
Borrowings₹2.62 Cr₹1.75 Cr₹3.22 Cr₹2.30 Cr
Current liabilities₹3.81 Cr₹1.59 Cr₹2.47 Cr₹2.41 Cr
Total liabilities₹7.82 Cr₹4.89 Cr₹6.86 Cr₹6.13 Cr
Current assets₹8.14 Cr₹5.93 Cr₹6.15 Cr₹5.32 Cr
Cash & equivalents₹1.84 Cr₹2.27 Cr₹1.88 Cr₹1.68 Cr
Total assets₹17.20 Cr₹15.94 Cr₹10.53 Cr₹9.57 Cr
Employees334332313109
Gain deeper financial insights of this entity

Audited financials & ratios for Cyamopsisbiotech.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Compounded Annual Growth Rate

Derived from multi-FY filingsLocked
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue₹12.64 Cr+10.5%+21.5%+6.0%
Profit after Tax₹68.69 L-2.4%+11.2%+19.1%
Net Worth₹9.39 Cr-11.9%+26.7%+5.6%
Employees334+7.0%+25.3%+21.1%
Gain deeper financial insights of this entity

Audited financials & ratios for Cyamopsisbiotech.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Financial Ratios

Profitability · leverage · efficiencyLocked
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
FY2024-25₹12.64 Cr₹68.69 L+5.43%+26.28%+7.32%+3.99%0.28₹3.78 L
FY2023-24₹11.80 Cr₹68.03 L+5.77%-3.12%+6.16%+4.27%0.16₹3.55 L
FY2022-23₹10.23 Cr₹59.34 L+5.80%+36.58%+16.16%+5.64%0.88₹3.27 L
FY2021-22₹9.45 Cr₹70.19 L+7.43%+33.77%+20.40%+7.33%0.67₹8.67 L
Gain deeper financial insights of this entity

Audited financials & ratios for Cyamopsisbiotech.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters11,65,73,78858.96%
Institutional Investors321,56,2877.67%
Public & Others2793,81,29633.37%
See the full shareholding pattern

Promoter, institutional & public holding for Cyamopsisbiotech.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

146 peersSame sector + state + ±5y vintage
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
—
PAT (latest FY)
—
Employees
—
—
—
—
Paid-up capital
—
Compliance Health
63
96
96
Bottom quartile · P1

Top 10 in Agriculture

by healthView all ›
01
Shreeoswal Seeds And Chemicals Limited
Madhya Pradesh · Inc 2017
Paid-up
Revenue
A · 96
02
Advanta Enterprises Limited
Maharashtra · Inc 2022
Paid-up
Revenue
A · 96
03
Paid-up
Revenue
A · 96
04
Paid-up
Revenue
A · 96
05
Paid-up
Revenue
A · 96
06
Paid-up
Revenue
A · 96
07
Paid-up
Revenue
A · 96
08
Paid-up
Revenue
A · 96
09
Paid-up
Revenue
C · 63
10
Gofrugal
Karnataka · Inc 2004
Paid-up
Revenue
C · 63

Events & timeline

2Filings, charges, board changes
14 Mar 2012
Suresh appointed as Director
14 Mar 2012
Anju appointed as Director

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Cyamopsisbiotech

When was Cyamopsisbiotech incorporated?
Cyamopsisbiotech was incorporated in 2018. Its CIN is U01136HR2012PTC045395 and it is registered with the relevant Registrar of Companies.
Where is Cyamopsisbiotech located?
Cyamopsisbiotech is headquartered in Haryana.
What sector does Cyamopsisbiotech operate in?
Cyamopsisbiotech operates in the Agriculture sector (NIC code 01136), classified as Indian Non-Govt Company.
Who are the directors of Cyamopsisbiotech?
Director details for Cyamopsisbiotech have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Cyamopsisbiotech?
Cyamopsisbiotech has authorized capital of — and paid-up capital of —.
Does Cyamopsisbiotech have any open charges?
Cyamopsisbiotech has no open MCA-registered charges on record.
What is Cyamopsisbiotech's Compliance Health Score?
RegisterKaro's Compliance Health Score for Cyamopsisbiotech is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.